
Valerie Rodriguez-garcia
Examiner (ID: 13670, Phone: (571)270-5865 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1622, 1621, 1759, 1626 |
| Total Applications | 1146 |
| Issued Applications | 752 |
| Pending Applications | 83 |
| Abandoned Applications | 331 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20750265
[patent_doc_number] => 20260152487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-06-04
[patent_title] => PHTHALAZINE DERIVATIVES AS PYRUVATE KINASE MODULATORS
[patent_app_type] => utility
[patent_app_number] => 18/707418
[patent_app_country] => US
[patent_app_date] => 2022-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86381
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -45
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18707418
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/707418 | PHTHALAZINE DERIVATIVES AS PYRUVATE KINASE MODULATORS | Nov 3, 2022 | Pending |
Array
(
[id] => 19876860
[patent_doc_number] => 20250109117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-03
[patent_title] => FLUORINE-CONTAINING PYRIMIDINE COMPOUNDS, HARMFUL FUNGUS CONTROL AGENT, AND METHOD FOR PRODUCING FLUORINE-CONTAINING PYRIMIDINE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/709340
[patent_app_country] => US
[patent_app_date] => 2022-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15047
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18709340
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/709340 | Fluorine-containing pyrimidine compounds, harmful fungus control agent, and method for producing fluorine-containing pyrimidine compounds | Oct 30, 2022 | Issued |
Array
(
[id] => 18311188
[patent_doc_number] => 20230115088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => 3-Methylideneoxan-4-One Compounds and Substituted Derivates Thereof as Inhibitors of Telomerase
[patent_app_type] => utility
[patent_app_number] => 17/965352
[patent_app_country] => US
[patent_app_date] => 2022-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19552
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17965352
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/965352 | 3-methylideneoxan-4-one compounds and substituted derivates thereof as inhibitors of telomerase | Oct 12, 2022 | Issued |
Array
(
[id] => 19629672
[patent_doc_number] => 20240408121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-12
[patent_title] => NUTRITIONAL COMPOSITION FOR IMPROVING SLEEP
[patent_app_type] => utility
[patent_app_number] => 18/700600
[patent_app_country] => US
[patent_app_date] => 2022-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8467
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18700600
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/700600 | NUTRITIONAL COMPOSITION FOR IMPROVING SLEEP | Oct 12, 2022 | Pending |
Array
(
[id] => 19599522
[patent_doc_number] => 20240390402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-28
[patent_title] => COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/700691
[patent_app_country] => US
[patent_app_date] => 2022-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7777
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18700691
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/700691 | COMPOSITION | Oct 11, 2022 | Pending |
Array
(
[id] => 18295782
[patent_doc_number] => 20230105468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => CONJUGATION METHODS
[patent_app_type] => utility
[patent_app_number] => 17/964168
[patent_app_country] => US
[patent_app_date] => 2022-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16015
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17964168
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/964168 | CONJUGATION METHODS | Oct 11, 2022 | Abandoned |
Array
(
[id] => 18282022
[patent_doc_number] => 20230097494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => DEUTERATED SECNIDAZOLE FOR USE IN THE TREATMENT OF BACTERIAL VAGINOSIS AND METHODS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/963942
[patent_app_country] => US
[patent_app_date] => 2022-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23496
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17963942
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/963942 | DEUTERATED SECNIDAZOLE FOR USE IN THE TREATMENT OF BACTERIAL VAGINOSIS AND METHODS AND USES THEREOF | Oct 10, 2022 | Abandoned |
Array
(
[id] => 18282022
[patent_doc_number] => 20230097494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => DEUTERATED SECNIDAZOLE FOR USE IN THE TREATMENT OF BACTERIAL VAGINOSIS AND METHODS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/963942
[patent_app_country] => US
[patent_app_date] => 2022-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23496
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17963942
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/963942 | DEUTERATED SECNIDAZOLE FOR USE IN THE TREATMENT OF BACTERIAL VAGINOSIS AND METHODS AND USES THEREOF | Oct 10, 2022 | Abandoned |
Array
(
[id] => 18373524
[patent_doc_number] => 20230148600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => PESTICIDALLY ACTIVE THIOPHENE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 18/045276
[patent_app_country] => US
[patent_app_date] => 2022-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25579
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18045276
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/045276 | PESTICIDALLY ACTIVE THIOPHENE DERIVATIVES | Oct 9, 2022 | Abandoned |
Array
(
[id] => 20077503
[patent_doc_number] => 12351553
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-08
[patent_title] => Process for producing 5-aryl-1H-pyrolle-3-carbonitrile compounds by dehalogenation
[patent_app_type] => utility
[patent_app_number] => 17/961978
[patent_app_country] => US
[patent_app_date] => 2022-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26737
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17961978
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/961978 | Process for producing 5-aryl-1H-pyrolle-3-carbonitrile compounds by dehalogenation | Oct 6, 2022 | Issued |
Array
(
[id] => 18282382
[patent_doc_number] => 20230097854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => METHODS FOR CONVERTING THC-RICH CANNABINOID MIXTURES INTO CBN-RICH CANNABINOID MIXTURES
[patent_app_type] => utility
[patent_app_number] => 17/936308
[patent_app_country] => US
[patent_app_date] => 2022-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7499
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17936308
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/936308 | METHODS FOR CONVERTING THC-RICH CANNABINOID MIXTURES INTO CBN-RICH CANNABINOID MIXTURES | Sep 27, 2022 | Abandoned |
Array
(
[id] => 20206215
[patent_doc_number] => 20250275935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-04
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING PATIENTS WITH DEMENTIA DUE TO ALZHEIMER'S DISEASE WITH A COMBINATION OF THC AND MELATONIN
[patent_app_type] => utility
[patent_app_number] => 18/692705
[patent_app_country] => US
[patent_app_date] => 2022-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26360
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18692705
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/692705 | COMPOSITIONS AND METHODS FOR TREATING PATIENTS WITH DEMENTIA DUE TO ALZHEIMER'S DISEASE WITH A COMBINATION OF THC AND MELATONIN | Sep 15, 2022 | Pending |
Array
(
[id] => 19996688
[patent_doc_number] => 20250134910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-01
[patent_title] => COMPOSITION FOR TREATING CORONAVIRUS DISEASE 2019 (COVID-19) CONTAINING TAURODEOXYCHOLIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND ANTIVIRAL AGENT AS ACTIVE INGREDIENTS
[patent_app_type] => utility
[patent_app_number] => 18/694190
[patent_app_country] => US
[patent_app_date] => 2022-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3211
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18694190
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/694190 | COMPOSITION FOR TREATING CORONAVIRUS DISEASE 2019 (COVID-19) CONTAINING TAURODEOXYCHOLIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND ANTIVIRAL AGENT AS ACTIVE INGREDIENTS | Sep 14, 2022 | Pending |
Array
(
[id] => 18177973
[patent_doc_number] => 20230038702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => BRIGHT TARGETABLE RED CA2+ INDICATORS
[patent_app_type] => utility
[patent_app_number] => 17/940199
[patent_app_country] => US
[patent_app_date] => 2022-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18840
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17940199
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/940199 | Bright targetable red CA | Sep 7, 2022 | Issued |
Array
(
[id] => 18162068
[patent_doc_number] => 20230028660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => ANTI-CANCER COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/899297
[patent_app_country] => US
[patent_app_date] => 2022-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9428
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17899297
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/899297 | Anti-cancer compounds | Aug 29, 2022 | Issued |
Array
(
[id] => 18279115
[patent_doc_number] => 20230094587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => Simplified Structural Mimetics of AIPS as Quorum Sensing Inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/823053
[patent_app_country] => US
[patent_app_date] => 2022-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21725
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 278
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17823053
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/823053 | Simplified structural mimetics of AIPS as quorum sensing inhibitors | Aug 28, 2022 | Issued |
Array
(
[id] => 18270494
[patent_doc_number] => 20230091736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => CRYSTALLINE FORMS OF TENOFOVIR ALAFENAMIDE
[patent_app_type] => utility
[patent_app_number] => 17/885883
[patent_app_country] => US
[patent_app_date] => 2022-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28636
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17885883
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/885883 | Crystalline forms of tenofovir alafenamide | Aug 10, 2022 | Issued |
Array
(
[id] => 20671914
[patent_doc_number] => 12612414
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-28
[patent_title] => Nitrile SUMO inhibitors and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/576128
[patent_app_country] => US
[patent_app_date] => 2022-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 68964
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18576128
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/576128 | Nitrile SUMO inhibitors and uses thereof | Jul 20, 2022 | Issued |
Array
(
[id] => 18036085
[patent_doc_number] => 20220380300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => ALCOHOL DERIVATIVES AS KV7 POTASSIUM CHANNEL OPENERS
[patent_app_type] => utility
[patent_app_number] => 17/869116
[patent_app_country] => US
[patent_app_date] => 2022-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15704
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17869116
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/869116 | Alcohol derivatives as Kv7 potassium channel openers | Jul 19, 2022 | Issued |
Array
(
[id] => 19512034
[patent_doc_number] => 20240343720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => AAK1 INHIBITOR AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/579733
[patent_app_country] => US
[patent_app_date] => 2022-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28181
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18579733
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/579733 | AAK1 INHIBITOR AND USE THEREOF | Jul 13, 2022 | Pending |